Philippe Chêne, president of Winncare, highlights the key developments of the group over the past three years – most notably its acquisition of the UK player Mangar Health. Chêne goes on to comment on the French reimbursement and medtech environment, pointing out the strong ambitions of the new administration yet lack of consistency within the overall structure of the government.
Between Mangar and Winncare, the vast majority of our sales are still based in Europe. Our next focus market is absolutely the North American region
